Selective agonists for serotonin 7 (5-HT7) receptor and their applications in preclinical models: An overview

Reviews in the Neurosciences

Volumn 25, Issue 3, 2014, Pages 401-415

  Di Pilato, Pantaleo ^a   Niso, Mauro ^a   Adriani, Walter ^b   Romano, Emilia ^b,c   Travaglini, Domenica ^b   Berardi, Francesco ^a   Colabufo, Nicola A ^a   Perrone, Roberto ^a   Laviola, Giovanni ^b   Lacivita, Enza ^a   Leopoldo, Marcello ^a  

^a UNIVERSITY OF BARI   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

Author keywords

Learning; Long term depression; Memory; Neurite outgrowth; Pain; Thermoregulation

Indexed keywords

3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; AS 19; E 55888; LP 12; LP 211; LP 44; NEUROPROTECTIVE AGENT; SEROTONIN 7 RECEPTOR; SEROTONIN 7 RECEPTOR AGONIST; SEROTONIN AGONIST; UNCLASSIFIED DRUG; SEROTONIN RECEPTOR;

ANXIETY; AREA UNDER THE CURVE; CIRCADIAN RHYTHM; DEPRESSION; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; MAXIMUM PLASMA CONCENTRATION; MEMORY; NEUROPROTECTION; NOCICEPTION; NONHUMAN; REM SLEEP; REVIEW; SCHIZOPHRENIA; THERMOREGULATION; ANIMAL; CHEMISTRY; DRUG EFFECT; DRUG SCREENING; HUMAN; LEARNING; METABOLISM; NEUROLOGIC DISEASE; RAT;

ANIMALS; BODY TEMPERATURE REGULATION; CIRCADIAN RHYTHM; DRUG EVALUATION, PRECLINICAL; HUMANS; LEARNING; NERVOUS SYSTEM DISEASES; RATS; RECEPTORS, SEROTONIN; SEROTONIN RECEPTOR AGONISTS;

EID: 84907169186     PISSN: 03341763     EISSN: 21910200     Source Type: Journal    
DOI: 10.1515/revneuro-2014-0009     Document Type: Review

References (90)

1. Adriani W. Travaglini D. Lacivita E. Saso L. Leopoldo M. and Laviola G. (2012). Modulatory effects of two novel agonists for serotonin receptor 7 on emotion motivation and circadian rhythm profiles in mice. Neuropharmacology 62 833-8 42
2. Atanes P. Lacivita E. Rodr íguez J. Brea J. Burgueño J. Vela J.M. Cadavid M.I. Loza M.I. Leopoldo M. and Castro M. (2013). The arylpiperazine derivatives N-(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamide (LP-211) and N-benzyl-4-(2-diphenyl)-1-piperazinehexanamide (MEL-9) exert a long-lasting inhibition of human serotonin 5-HT7 receptor binding and cAMP signaling. Pharmacol Res Perpect 1 DOI: 10.1002/prp2.13
3. Ballaz S.J. Akil H. and Watson S.J. (2007). The 5-HT7 receptor: role in novel object discrimination and relation to novelty-seeking behavior. Neuroscience 149 192-202
4. Bard J.A. Zgombick J. Adham N. Vaysse P. Branchek T.A. and Weinshank R.L. (1993). Cloning of a novel human serotonin receptor (5-HT7) positively linked t o adenylate cyclase. J. Biol. Chem. 268 23422-23426
5. Berry-Kravis E. Knox A. and Hervey C. (2011). Targeted treatments for fragile X syndrome. J. Neurodev. Disord. 3 193-210
6. Boddeke H.W. Fargin A. Raymond J.R. Schoeffter P. and Hoyer D. (1992). Agonist/antagonist interactions with cloned human 5-HT1A receptors: variations in intrinsic activity studied in transfected HeLa cells. Naunyn . Schmiedeberg's Arch. Pharmacol. 345 257-263
7. Bonaventure P. Nepomuceno D. Kwok A. Chai W. Langlois X. Hen R. Stark K. Carruthers N. and Lovenberg T.W. (2002). Reconsid eration of 5-hydroxytryptamine (5-HT)7 receptor distribution using [3H]5-carboxamidotryptamine and [3H]8-hydroxy-2-(di-n-propylamino)tetraline: analysis in brain of 5-HT1A knockout and 5-HT1A/1B double-knockout mice. J. Pharmacol. Exp. Ther. 302 240-248
8. Bonaventure P. Kelly L. Aluisio L. Shelton J. Lord B. Galici R. Miller K. Atack J. Lovenberg T.W. and Dugovic C. (2007). Selective blockade of 5-hydroxytryptamine ( 5-HT)7 receptors enhances 5-HT transmission antidepressant-like behavior and rapid eye movement sleep suppression induced by citalopram in rodents. J. Pharmacol. Exp. Ther. 321 690-698
9. Brenchat A. Romero L. Garc ía M. Pujol M. Burgueñ o J. Torrens A. Hamon M. Baeyens J.M. Buschmann H. Zamanillo D. et al. (2009). 5-HT7 receptor activation inhibits mechanical hypersensitivity secondary to capsaicin sensitization in mice. Pain 141 239-247
10. Brenchat A. Nadal X. Romero L. Ovalle S. Muro A. Sánchez-Arroyos R. Portillo-Salido E. Pujol M. Montero A. Codony X. et al. (2010). Pharmacological activation of 5-HT7 receptors reduces nerve injury-induced mechanical and thermal hypersensitivity. Pain 149 483-494
11. Brenchat A. Ejarque M. Zamanillo D. Vela J.M. and Romero L. (2011). Potentiation of morphine analgesia by adjuvant activation of 5-HT7 receptors. J. Pharmacol. Sci. 116 388-391
12. Brenchat A. Rocasalbas M. Zamanillo D. Hamon M. Vela J.M. and Romero L. (2012). Assessment of 5-HT7 Receptor agonists selectivity using nociceptive and thermoregulation tests in knockout versus wild-type mice. Adv. Pharmacol. Sci. 2012 312041
13. Carter D. Champney M. Hwang B. and Eglen R.M. (1995). Characterization of a postjunctional 5-HT receptor mediating relaxation of guinea-pig isolated ileum. Eur. J. Pharmacol. 280 243-250
14. Cheung Z.H. and Ip N.Y. (2007). The roles of cyc lin-dependent kinase 5 in dendrite and synapse development. Biotechnol. J. 2 949-957.
15. Costa L.,Trovato C.,Musumeci S.A.,Catania M.V.,Ciranna L. (2012a), 5-HT1A and 5-HT7 receptors differently modulate AMPA receptor-mediated hippocampal synaptic transmission, Hippocampus, 22, 790-801
16. Costa L. Spatuzza M. D'Antoni S. Bonaccorso C.M. Trovato C. Musumeci S.A. Leopoldo M. Lacivita E. Catania M.V. and Ciranna L. (2012b). Activation of 5-HT7 serotonin receptors reverses metabotropic glutamate receptor-mediated synaptic plasticity in wild-type and Fmr1 knockout mice a model of Fragile X s yndrome. Biol. Psych. 72 924-933
17. Cutrer F.M. Moussaoui S. Garret C. and Moskowitz M.A. (1995). The nonpeptide neurokinin-1 antagonist RPR 100893 decreases c-fos expression in trigeminal nucleus ca udalis following noxious chemical meningeal stimulation. Neuroscience 64 741-750
18. Dean B. Pavey G. Thomas D. and Scarr E. (2006). Cortical serotonin7 1D and 1F receptors: effects of schizophrenia suicide and antipsychotic drug treatment. Schizophr. Res. 88 265-267
19. De Bie J.J. Henricks P.A. Cruikshank W.W. Hofman G. Jonker E.H. Nijkamp F.P. and Van Oosterhout A.J. (1998). Modulation of airway hyperresponsiveness and eosinophilia by selective histamine and 5-HT receptor antagonists in a mouse model of allergic asthma. Br. J. Pharmacol. 124 857-864
20. Dogrul A. and Seyrek M. (2006). Systemic morphine produce antinociception mediated by spinal 5-HT7 but not 5-HT1A and 5-HT2 receptors in the spinal cord. Br. J. Pharmacol. 149 498-505
21. Dogrul A. Ossipov M.H. and Porreca F. (2009). Differ ential mediation of descending pain facilitation and inhibition by spinal 5HT3 and 5HT7 receptors. Brain Res. 1280 52-59
22. Egawa-Tsuzuki T. Ohno M. Tanaka N. Takeuchi Y. Uramoto H. Faigle R. Funa K. Ishii Y. and Sasahara M. (2004). The PDGF B chain is involved in the ontogenic susceptibility of the developing rat brain to NMDA toxicity. Exp. Neurol. 186 89-98
23. Eriksson T.M. Holst S. Stan T.L. Hager T. Sjögren B. Ogren S.Ö . Svenningsson P. and Stiedl O. (2012). 5-HT1A and 5-HT7 receptor crosstalk in the regulation of emotional memory: implications for effects of selective serotonin reuptake inhibitors. Neuropharmacology 63 150-160
24. Gilchrist H.D. Allard B.L. and Simone D.A. (1996). Enhanced withdrawal responses to heat and mechanical stimuli following intraplantar injection of capsaicin in rats. Pain 67 179-188
25. Glass J.D. Grassman G.H. Farnbauch L. and Di Nardo L. (2003). Midbrain raphe modulation of nonphotic circadian clock resetting and 5-HT release in the mammalian suprachiasmatic nucleus. J. Neurosci. 23 7451-7460
26. Guscott M.R. Egan E. Cook G.P. Stanton J.A. Beer M.S. Rosahl T.W. Hartmann S. Kulagowski J. McAllister G. Fone K.C. et al. (2003). The hypothermic effect of 5-CT in mice is mediated through the 5-HT7 receptor. Neuropharmacology 44 1031-1037
27. Guscott M. Bristow L.J. Handingham K. Rosahl T.W. Beer M.S. Stanton J.A. Bromidge F. Owens A.P. Huscroft I. Myers J. et al. (2005). Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression. Neuropharmacology 48 492-502
28. Hagan J.J. Price G.W. Jeffrey P. Deeks N.J. Stean T. Piper D. Smith M.I. Upton N. Medhurst A.D. Middlemiss D.N. et al. (2000). Characterization of SB-269970-A a selective 5-HT7 receptor antagonist. Br. J. Pharmacology 130 539-548
29. Hedlund P.B. and Sutcliffe J.G. (2007). The 5-HT7 receptor influences stereotypic behavior in a model of obsessivecompulsive disorder. Neurosci Lett. 414 247-251
30. Hedlund P.B. Danielson P.E. Thomas E.A. Slanina K. Carson M.J. and Sutcliffe J.G. (2003). No hypothermic response to serotonin in 5-HT7 receptor knockout mice. Proc. Natl. Acad. Sci. USA 100 137 5-1380
31. Hedlund P.B. Huitron-Resendiz S. Henriksen S.J. and Sutcliffe J.G. (2005). 5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern. Biol. Psych. 58 831-837
32. Hedlund P.B. Leopoldo M. Caccia S. Sarkisyan G. Fracasso C. Martelli G. Lacivita E. Berardi F. and Perrone R. (2010). LP-211 is a brain penetrant selective agonist for the serotoni n 5-HT(7) receptor. Neurosci Lett. 481 12-16
33. Hegde S.S. and Eglen R.M. (1996). Peripheral 5-HT4 receptors. FASEB J. 10 1398-1407
34. Hoyer D. Hannon J.P. and Martin G. R. (2002). Molecular pharmacological and functional diversity of 5-HT receptors. Pharmacol. Biochem. Behav. 71 533-554
35. Krupinski J. Issa R. Bujny T. Slevin M. Kumar P. Kumar S. and Kaluza J. (1997). A putative role for platelet-derived growth factor in angiogenesis and neuroprotection after ischemic stroke in humans. Stroke 28 564-573.
36. Kvachnina E.,Liu G.,Dityatev A.,Renner U.,Dumuis A.,Richter D.W.,Dityateva G.,Schachner M.,Voyno-Yasenetskaya T.A.,Ponimaskin E.G., 2005, 5-HT7 receptor is coupled to Gńsubunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology, J. Neurosci, 25, 7821-7830
37. Lacivita E. Patarnello D. Stroth N. Caroli A. Niso M. Contino M. De Giorgio P. Di Pilato P. Colabufo N.A. Berard i F. et al. (2012). Investigations on the 1-(2-biphenyl) piperazine motif: identification of new potent and selective ligands for the serotonin7 (5-HT7) receptor with agonist or antagonist action in vitro or ex vivo. J. Med. Chem. 55 6375-6380
38. Lee T. Winter C. Marticke S.S. Lee A. and Luo L. (2000). Essential roles of Drosophila RhoA in the regulation of neuroblast proliferation and dendritic but not axonal morphogenesis. Neuron 25 307-316
39. Leo D. Adriani W. Cavaliere C. Cirillo G. Marco E.M Romano E. di Porzio U. Papa M. Perrone-Capano C. and Laviola G. (2009). Methylphenidate to adolesc ent rats drives enduring changes of accumbal Htr7 expression: implications for impulsive behavior and neuronal morphology. Genes Brain Behav. 8 356-368
40. Leopoldo M. Berardi F. Colabufo N.A. Contino M. Lacivita E. Niso M. Perrone R. and Tortorella V. (2004). Structure-affinity relationship study on N-(1234-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides a new class of 5-hydroxytryptamine7 receptor age nts. J. Med. Chem. 47 6616-6624
41. Leopoldo M. Lacivita E. Contino M. Colabufo N.A. Berardi F. and Perrone R. (2007). Structure-activity relationship study on N-(1234-tetrahydronaph thalen-1-yl)-4-aryl-1-piperazinehexanamides a class of 5-HT7 receptor agents. 2. J. Med. Chem. 50 4214-4221
42. Leopoldo M. Lacivita E. De Giorgio P. Fracasso C. Guzzetti S. Caccia S. Contino M. Colabufo N.A. Berardi F. and Perrone R. (2008). Structural modifications of N-(1234-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides: influence on lipophilicity and 5-HT7 receptor activity. Part III. J. Med. C hem. 51 5813-5822
43. Leopoldo M. Lacivita E. Berardi F. and Perrone R. (2010). 5-HT7 receptor modulators: a medicinal chemistry survey of recent patent literature (2004- 2009). Exp. Opin. Ther. Patents. 20 739-754
44. Leopoldo M. Lacivita E. Berardi F. Perrone R. and Hedlund P.B. (2011). Serotonin 5-HT7 receptor agents: structure-activity relationships and potential therapeutic applications in central nervous system disorders. Pharmacol. Ther. 129 120-148
45. Li Z. Van Aelst L. and Cline H.T. (2000). Rho GTPases regulate distinct aspects of dendritic arbor growth in Xenopus central neurons in vivo. Nat. Neurosci. 3 217-225
46. Lovenberg T.W. Baron B.M. de Lecea L. Mill er J.D. Prosser R.A. Rea M.A. Foye P.E. Racke M. Slone A.L. Siegel B.W. et al (1993). A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhy thms. Neuron 11 449-458
47. Luscher C. and Huber K.M. (2010). Group 1 mGluR-dependent synaptic longterm depression: mechanisms and implications for circuitry and disease. Neuron 65 445-459
48. Mahe C. Loetscher E. Dev K.K. Bobirnac I. Otten U. and Schoeffter P. (2005). Serotonin 5-HT7 receptors coupled to induction of interleukin-6 in human microglial MC-3 cells. Neuropharmacology 49 40-47
49. Manuel-Apolinar L. and Meneses A. (2004). 8-OH-DPAT facilitated memory consolidation and increased hippocampal and cortical camp production. Behav. Brain Res. 148 179-184
50. Martínez-Gar cía E. Leopoldo M. Lacivita E. and Terrón J.A. (2011). Increase of capsaicin-induced trigeminal Fos-like immunoreactivity by 5-HT7 receptors. Headache 51 1511-1519
51. Matsuo N. Reijmers L. and Mayford M. (2008). Spine-typespecific recruitment of newly synthesized AMPA receptors with learning. Science 319 1104-1107
52. Meneses A. (2004). Effects of the 5-HT7 receptor antagonists SB-269970 and DR-4004 in autoshaping Pavlovian/instrumental learning task. Behav. Brain Res. 155 275-282
53. Meneses A. Perez-Garcia G. Liy-Salmeron G. Flores-Galvez D. Castillo C. and Castillo E. (2008). The effects of the 5-HT6 receptor agonist EMD and the 5-HT7 receptor agonist AS-19 on memory formation. Behav. Brain Res. 195 112-119
54. Mitsikostas D.D. Sanchez del Rio M. Waeber C. Moskowitz M.A. and C utrer F.M. (1998). The NMDA receptor antagonist MK-801 reduces capsaicin-induced c-fos expression within rat trigeminal nucleus caudalis. Pain 76 239-248
55. Mnie-Filali O. Lambá s-Señas L. Zimmer L. and Haddjeri N. (2007). 5-HT7 receptor antagonists as a new class of antidepressants. Drug News Perspect. 20 613-618
56. Mnie-Filali O. Faure C. Lambás-Señas L. El Mansari M. Belblidia H. Gondard E. Etié vant A. Scarna H. Didier A. Berod A. et al. (2011). Pharmacological blockade of 5-HT7 receptors as a putative fast acting antidepressant strategy. Neuropsychopharmacology 36 1275-128 8
57. Naumenko V.S. Kondaurova E.M. and Popova. N-K. (2011). On the role of brain 5-HT7 receptor in the mechanism of hypothermia: comparison with hypothermia mediated via 5-HT1A and 5-HT3 receptor. Neuropharmacology 61 1360-1365.
58. Nichols D.E.,Nichols C.D., 2008, Serotonin receptors. Chem. Rev., 108, 1614-1641
59. Nikolic M. Dudek H. Kwon Y.T. Ramos Y.F.M. and Tsai L.H. (1996). The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev. 10 816-825
60. Nozaki K. Boccalini P. and Moskowitz M.A. (1992). Expres sion of c-fos-like immunoreactivity in brainstem after meningeal irritation by blood in the subarachnoid space. Neuroscience 49 669-680
61. Perez-Garcia G.S. and Meneses A. (2005). Effects of the potential 5-HT 7 receptor agonist AS-19 in an autoshaping learning task. Behav. Brain Res. 163 136-140
62. Perron J.C. and Bixby J.L. (1999). Distinct neurite outgrowth signaling pathways converge on ERK activation. Mol. Cell Neurosci. 13 362-378
63. Pittalà V. Salerno L. Modica M. Siracusa M.A. and Romeo G. (2007). 5-HT7 receptor ligands: recent developments and potential therapeutic applications. Mini-Rev. Med. Chem. 7 945-960
64. Ponimaskin E. Voyno-Yasenetskaya T. Richter D.W. Schachner M. and Dityatev A. (2007). Morphogenic signaling in neurons via neurotransmitter receptors and small GTPases. Mol. Neurobiol. 35 278-287
65. Roberts A.J. and Hedlund P.B. (2012). The 5-HT7 receptor in learning and memory. Hippocampus 22 762-771
66. Roberts A.J. Krucker T. Levy C.L. Slanina K.A. Sutcliffe J.G. and Hedlund P.B. (2004). Mice lacking 5-HT7 receptors show specific impairments in contextual learning. Eur. J. Neuroscience 19 1913-1922
67. Romano. E. Ruocco L.A. Nativo P. Lacivita E. Ajmone-Cat M.A. Boatto G. Nieddu M. Tino A. Sadile A.G. Passarelli F. et al. (2014). Modulatory effects following subchronic stimulation of brain 5-HT7-R system in mice and rats. Rev. Neurosci . 25 383-400
68. Ruat M. Traiffort E. Leurs R. Tardivel-Lacombe J. Diaz J. Arrang J.M. and Schwartz J.C. (1993). Molecular cloning characterization and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc. Natl. Acad. Sci USA 90 8547-8551
69. Ruocco L.A. Romano E. Treno C. Lacivita E. Claudio A. Gironi-Carnevale U.A. Travaglini D. Leopoldo M. Laviola G. Sadile A.G. et al. (2013). Emotional and risk seeking behavior after prepuberal subchronic or adult acute stimulation of 5-HT7-Rs in naples high excitability rats. Synapse doi: 10.1002/syn.21724
70. Sakata M. Yanamoto H. Hashimoto N. Iihara K. Tsukahara T. Taniguchi T. and Kikuchi H. (1998). Induction of infarct tolerance by platelet-derived growth factor against reversible focal ischemia. Brai n Res. 784 250-255
71. Sanderson D.J. Good M.A. Seeburg P.H. Sprengel R. Rawlins J.N. and Bannerman D.M. (2008). The role of the GluR-A (GluR1) AMPA receptor subunit in learning and memory. Prog. Brain Res. 169 159-178
72. Sanin A. Brisander M. Rosqvist S. Mohell N. Malberg A. and Johansson A. (2004). 5-Aryl substituted (S)-2-(dimethylamino)-tetralins novel serotonin 5HT7 receptor ligands. In: Proceedings of the 14th Camerino-Noord Symposium. Ongoing Progress in the Receptor Chemistry 27
73. Sarkisyan G. and Hedlund P.B. (2009). The 5-HT7 receptor is involved in allocentric spatial memory information processing. Behav. Brain Res. 202 26-31
74. Sebok A. Nusser N. Debreceni B. Guo Z. Santos M.F. Szeberenyi J. and Tigyi G. (1999). Different roles for RhoA during neurite initiation elongation and regeneration in PC12 cells. J. Neurochem. 73 949-960
75. Segura P. Vargas M.H. C órdoba-Rodríguez G. Chávez J. Arreola J.L. Campos-Bedolla P. Ruiz V. García-Hernández L.M. Mé ndez C. and Montañ o L.M. (2010). Role of 5-HT2A 5-HT4 and 5-HT7 receptors in the antigen-induced airway hyperresponsiveness in guinea-pigs. Clin. Exp. Allergy 40 327-338
76. Sharp T. Backus L.I. Hjorth S. Bramwell S.R. and Grahame-Smith D.G. ( 1990). Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist BMY 7378. Eur. J. Pharmacol. 176 331-340
77. Shen Y. Monsma F.J. Jr Metcalf M.A. Jose P.A. Hamblin M.W. and Sibley D.R. (1993). Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J. Biol. Chem. 268 18200-18204
78. Smith C. Toohey N. Knight J.A. Klein M.T. and Teitler M. (2011). Risperidone-induced inactivation and clozapine-induced reactivation of rat cortical astrocyte 5-hydroxytryptamine? receptors: evidence for in situ G proteincoupled receptor homodimer protomer cross-talk. Mol. Pharmac ol. 79 318-325.
79. Speranza L.,Chambery A.,Di Domenico M.,Crispino M.,Severino V.,Volpicelli F.,Leopoldo M.,Bellenchi G.C.,di Porzio U.,Perrone-Capano C. (2013). The serotonin receptor 7 promotes neurite outgrowth via ERK and Cdk5 signaling pathways, Neuropharmacology, 67, 155-167
80. Tajiri M. Hayata-Takano A. Seiriki K. Ogata K. Hazama K. Shintani N. Baba A. and Hashimoto H. (2012). Serotonin 5-HT7 receptor blockade reverses behavioral abnormalities in PACAP-deficient mice and receptor activation promotes neurite extension in primary embryonic hippocampal neurons: therapeutic implications for psychiatric disorders. J. Mol. Neurosci. 48 473-481
81. Terron J.A. and Falcon-Neri A. (1999). Pharmacological evidence for the 5-HT7 receptor mediating smooth muscle relaxation in canine cerebral arteries. Br. J. Pharmacol. 127 609-616
82. Thomas D.R. Gittins S.A. Collin L.L. Middlemiss D.N. Riley G. Hagan J.J. Gloger I. E. Ellis C. Forbes I.T. and Brown A.M. (1998). Functional characterization of the human cloned 5-HT7 receptor (long form); antagonist profile of SB-258719. Br. J. Pharmacol. 124 1300-1306
83. Thomas D.R. Melotto S. Massagrande M. Gribble A.D. Jeffrey P. Ste vens A.J. Deeks N.J. Eddershaw P.J. Fenwick S.H. Riley G. et al. (2003). SB-656104-A a novel selective 5-HT7 receptor antagonist modulates REM sleep in rats. Br. J. Pharmacol. 139 705-714
84. Tseng H.C. and Dichter M.A. (2005). Platelet-derived growth factor-BB pretreatment attenuates excitotoxic death in cultured hippocampal neurons. Neurobiol. Dis. 19 77-83
85. Vasefi M.S. Kruk J.S. Liu H. Heikkila J.J. and Beazely M.A. (2012). Activation of 5-HT7 receptors increases neuronal platelet-derived growth factor α-receptor expression. Neurosci. Lett. 511 65-69
86. Vasefi M.S. Kruk J.S. Heikkila J.J. and Beazely M.A. (2013). 5-Hydroxytryptamine type 7 receptor neuroprotection against NMDA-induced excitotoxicity is PDGF-receptor dependent. J. Neurochem. 125 26-36
87. Wesolowska A. Nikiforuk A. and Stachowicz K. (2006 a ). Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB269970 after intrahippocampal administration to rats. Eur. J. Pharm. 553 185-190
88. Wesolowska A. Nikiforuk A. Stachowicz K. and Tatarczynska E. (2006b ). Effect of the selective 5-HT7 receptor antagonist SB269970 in animal models of anxiety and depression. Neuropharmacology 51 578-586
89. Xu Y. Zhang C. Wang R. Govindarajan S.S. Barish P.A. Vernon M.M. Fu C. Acharya A.P. Chen L. Boykin E. et al. (2011). Corticosterone induced morphologi cal changes of hippocampal and amygdaloid cell lines are dependent on 5-HT7 receptor related signal pathway. Neuroscience 182 71-81
90. Yanarates O. Dogrul A. Yildirim V. Sahin A. Sizlan A. Seyrek M. Akgül O. Kozak O. Kurt E. and Aypar U. (2010). Spinal 5-HT7 receptors play an important role in the antinociceptive and antihyperalgesic effects of tramadol and its metabolite odesmethyltramadol via activation of descen ding serotonergic pathways. Anesthesiology 112 696-710